Optimization of Soluble Expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD Fusion Proteins as Candidates for COVID-19 Intranasal Vaccines
Simson Tarigan, S. Sumarningsih, A. Apas, A. Apas, Ronald Tarigan, Riyandini Putri, Damai Ria Setyawati
The paper investigates the soluble expression of two fusion proteins for COVID-19 intranasal vaccines, finding that solubility can be improved with specific cultivation conditions and detergents.
PLoS ONE · Dec 26, 2024Peer-reviewedImmunology